Findings suggest a combination of therapies that may be effective in treating resistant prostate cancers
News: Cancer ResearchNext Page »« Previous Page
Vanderbilt University investigators have discovered a new molecular mechanism that regulates the dynamics of microtubules, which form the cell’s internal skeleton. The unexpected finding, reported in Developmental Cell, has implications for cancer drug discovery,
For years, scientists have known that regular aspirin use may reduce the risk of cancer. “Studies have shown that aspirin administration for five or more years reduces the incidence of all cancers by 38 percent,” said Pierre Massion, M.D., professor of Medicine and Cancer Biology and director of the Thoracic Program at Vanderbilt-Ingram Cancer Center. […]
The American Association for Cancer Research (AACR) Cancer Progress Report 2014, released Sept. 16, details advances in cancer research and treatment — and calls for increased research support.
FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common, a recent study has found.
Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.
Brian Engelhardt, M.D., MSCI, assistant professor of Medicine, has received a Mentored Career Development Award from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health, to explore the causes of post-transplant diabetes development.
Lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways, a recent study suggests.
Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications. Detecting these redox modifications as they occur in proteins is delicate work, “like trying to catch a fairy in a jar,” said Daniel Liebler, Ph.D., Ingram Professor of Cancer […]
Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.